H.W. Herr

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

39h-index6.1kcitations100works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(59), Urinary and Genital Oncology Studies(37), Testicular diseases and treatments(20), Urological Disorders and Treatments(12), Renal cell carcinoma treatment(10)

Publications100 total

EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

180 cited

Annals of Oncology·2019· 180 citedOpen Access

Is restaging transurethral resection (TUR) necessary in patients with non-muscle invasive bladder cancer (NMIBC) and focal lamina propria invasion?

European Urology Supplements·2017

Konventionelle Zystoskopie versus Narrow Band Imaging

Urologie Scan·2015

Robust Risk Stratification Model Predicts Local-Regional Recurrence After Radical Cystectomy in Different Patient Cohorts

1 cited

International Journal of Radiation Oncology*Biology*Physics·2013· 1 citedOpen Access

Radical Cystectomy and Orthotopic Urinary Reconstruction in Patients With Bladder Cancer After Renal Transplantation: Clinical Outcomes and Description of Technique

17 cited

Transplantation Proceedings·2013· 17 citedOpen Access

Radical Cystectomy and Urinary Diversion after Renal Transplantation

1 cited

Transplantation·2012· 1 cited

Bladder Cancer after Renal Transplantation

Transplantation·2012

433 EFFICACY AND SAFETY OF MYCOBACTERIAL CELL WALL DNA COMPLEX IN THE TREATMENT OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER AT HIGH RISK OF PROGRESSION AND WHO ARE REFRACTORY TO BCG

5 cited

European Urology Supplements·2011· 5 cited

673 THE IMPACT OF RESTAGING TUR ON OVERALL SURVIVAL IN PATIENTS WITH T1 TCC OF THE BLADDER

European Urology Supplements·2009

Efficacy of neo-adjuvant gemcitabine plus cisplatin (GC) in muscle-invasive urothelial cancer (UC)

13 cited

Journal of Clinical Oncology·2007· 13 cited

Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment

46 cited

Annals of Oncology·2006· 46 citedOpen Access

Safety and efficacy of intravesical bacillus Calmette-Guérin instillations in steroid-treated and immunocompromised patients

4 cited

Journal of Clinical Oncology·2006· 4 cited

Prospective trial of ifosfamide, paclitaxel, and cisplatin (ITP) in patients with advanced non-transitional cell (non-TCC) carcinomas of the urothelial tract

6 cited

Journal of Clinical Oncology·2006· 6 cited

Impact of body mass index on quality of surgery and survival outcomes in patients undergoing radical cystectomy for bladder cancer: A Cooperative Group Report

Journal of Clinical Oncology·2005

Optimal combined modality treatment improves outcome of locally advanced bladder cancer: Analysis of SWOG 8710

8 cited

Journal of Clinical Oncology·2005· 8 cited

Previous history of bladder cancer as a prognostic factor for patients diagnosed with transitional cell carcinoma of the upper urinary tract

3 cited

Journal of Clinical Oncology·2004· 3 cited

Previous history of bladder cancer as a prognostic factor for patients diagnosed with transitional cell carcinoma of the upper urinary tract

Journal of Clinical Oncology·2004

Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality)

38 cited

British Journal of Urology·2003· 38 cited

Adherence to Surveillance Among Patients With Superficial Bladder Cancer

135 cited

JNCI Journal of the National Cancer Institute·2003· 135 citedOpen Access

Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

27 cited

Urologic Oncology Seminars and Original Investigations·2003· 27 cited

page 1 of 5Next →

Frequent Co-authors

Pramod C. Sogani(14), William R. Fair(13), George J. Bosl(11), Dean F. Bajorin(10), Willet F. Whitmore(10), Howard I. Scher(9), Joel Sheinfeld(7), Robert J. Motzer(7), Guido Dalbagni(6), M. Morse(6), Zuo‐Feng Zhang(5), Victor E. Reuter(5), Herbert F. Oettgen(5), Madhu Mazumdar(4), Nancy L. Geller(4), Michael J. Morse(4), Carlos Cordon‐Cardo(4), A. S. Sarkis(3), Robert A. Badalament(3), M R Melamed(3)